AOD9604 is a synthetic fragment of human growth hormone designed to influence fat metabolism, whereas GLP1 medications like Semaglutide act on gut and brain hormone pathways to reduce appetite and improve blood sugar
The "right" dose sits in a narrow window that depends on: Delivery method - injectable GHK-Cu vs topical GHK-Cu vs oral/sublingual GHK-Cu Goal - skin rejuvenation , hair and scalp support, wound healing , general anti-ageing Individual factors - age , skin type , baseline GHK levels , other peptides being stacked Natural plasma GHK falls from roughly 200 ng/ml at age 20 to around 80 ng/ml by age 60
This meticulous process is the bedrock of reliable, reproducible research
However, your specific schedule will depend on your individual response to treatment and any symptoms you may experience
Systemic reach
Although the dosage is lower, it is still highly effective for many patients